冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析(1)
摘要：目的 分析冠状动脉粥样硬化性心脏病合并糖尿病患者的血脂检验结果。方法 选取2017年1月～6月我院诊治的22例CHD合并糖尿病患者作为观察组，选取同期的22例CHD患者作为对照组，对两组患者进行血脂检测，对比其血脂、载脂蛋白-A和载脂蛋白-B水平。结果 观察组TG、TC、LDL-C指标分别为(2.71±1.31)mmol/L、(6.54±2.14)mmol/L、(3.74±0.81)mmol/L，均高于对照组的(1.79±0.14)mmol/L、(5.17±1.25)mmol/L、(2.27±0.41)mmol/L，观察组HDL-C为(2.73±0.85)mmol/L，低于对照组的(3.72±0.14)mmol/L，两组差异有统计学意义(P<0.05)。观察组载脂蛋白-A、载脂蛋白-B水平分别为(1.01±0.17)g/L、(0.68±0.01)g/L，低于对照组的(1.35±0.26)g/L、(0.89±0.14)g/L，差异具有统计学意义(P<0.05)。结论 对CHD合并糖尿病患者进行血脂检测，能有效诊断患者的继发性并发症，降低并发症发生率，临床诊断价值明显，可在临床推广。
, http://www.100md.com
关键词：冠状动脉粥样硬化性心脏病；糖尿病；血脂；脂蛋白-A；载脂蛋白-B
中圖分类号：R541.4；R587.1 文献标识码：A DOI：10.3969/j.issn.1006-1959.2018.04.057
文章编号：1006-1959(2018)04-0154-02
Abstract：Objective To analyze the results of blood lipid test in patients with coronary atherosclerotic heart disease(CHD) complicated with diabetes mellitus.Methods 22 patients with CHD complicated with diabetes mellitus were selected as observation group from January to June in 2017.22 patients with CHD in the same period were selected as control group.Blood lipids were measured in both groups，serum lipid，apolipoprotein-A and apolipoprotein-B levels were compared.Results The indexes of TG，TC and LDL-C in the observation group were(2.71±1.31)mmol/L and(6.54±2.14)mmol/L and(3.74±0.81)mmol/L respectively，they were all higher than those in the control group(1.79±0.14)mmol/L，(5.17±1.25)mmol/L，(2.27±0.41)mmol/L，and the HDL-C in the observation group was(2.73±0.85)mmol/L，which was lower than that in the control group(3.72±0.14)mmol/L，and the difference between the two group was statistically significant(P<0.05).The apolipoprotein-A and apolipoprotein-B levels in the observation group were(1.01±0.17)g/L and(0.68±0.01)g/L，respectively，which were lower than those in the control group(1.35±0.26)g/L and(0.89±0.14)g/L，the difference was statistically significant(P<0.05).Conclusion The detection of serum lipids in CHD patients with diabetes can effectively diagnose the secondary complications and reduce the incidence of complications.The clinical diagnosis value is obvious and can be popularized in clinical practice.
, 百拇医药
Key words：Coronary atherosclerotic heart disease；Diabetes mellitus；Blood lipid；Lipoprotein-A；Apolipoprotein-B
冠状动脉粥样硬化性心脏病(coronary atherosclerotic heart disease，CHD)是临床内科常见疾病，发病率较高，且逐年增加，进而加大了CHD合并糖尿病的几率。研究显示[1]，导致糖尿病患者死亡率关键因素之一就是心血管疾病，而使CHD发生的常见因素就是血脂异常。所以，在对CHD合并糖尿病患者进行治疗时，血脂水平能为临床治疗提供有效参考信息。选取本院22例CHD合并糖尿病患者和22例CHD患者进行血脂检测，现报道如下。
1资料与方法
1.1一般资料 选取2017年1月～6月我院诊治的22例CHD合并糖尿病患者作为观察组，选取同期的22例CHD患者作为对照组，本次研究经过医院伦理委员会批准。全部患者均同意参与此次研究，排除患有精神疾病、意识语言障碍、严重肝肾器官疾病等患者。观察组男10例，女12例，年龄33～76岁，平均年龄(57.65±2.74)岁；病程1～7年，平均病程(3.41±1.02)年。对照组男13例，女9例，年龄32～75岁，平均年龄(55.32±3.01)岁；病程1～7年，平均病程(3.41±1.02)年。两组患者在性别、年龄、病程等方面差异无统计学意义(P>0.05)，具有可比性。, http://www.100md.com(刘静)
, http://www.100md.com
关键词：冠状动脉粥样硬化性心脏病；糖尿病；血脂；脂蛋白-A；载脂蛋白-B
中圖分类号：R541.4；R587.1 文献标识码：A DOI：10.3969/j.issn.1006-1959.2018.04.057
文章编号：1006-1959(2018)04-0154-02
Abstract：Objective To analyze the results of blood lipid test in patients with coronary atherosclerotic heart disease(CHD) complicated with diabetes mellitus.Methods 22 patients with CHD complicated with diabetes mellitus were selected as observation group from January to June in 2017.22 patients with CHD in the same period were selected as control group.Blood lipids were measured in both groups，serum lipid，apolipoprotein-A and apolipoprotein-B levels were compared.Results The indexes of TG，TC and LDL-C in the observation group were(2.71±1.31)mmol/L and(6.54±2.14)mmol/L and(3.74±0.81)mmol/L respectively，they were all higher than those in the control group(1.79±0.14)mmol/L，(5.17±1.25)mmol/L，(2.27±0.41)mmol/L，and the HDL-C in the observation group was(2.73±0.85)mmol/L，which was lower than that in the control group(3.72±0.14)mmol/L，and the difference between the two group was statistically significant(P<0.05).The apolipoprotein-A and apolipoprotein-B levels in the observation group were(1.01±0.17)g/L and(0.68±0.01)g/L，respectively，which were lower than those in the control group(1.35±0.26)g/L and(0.89±0.14)g/L，the difference was statistically significant(P<0.05).Conclusion The detection of serum lipids in CHD patients with diabetes can effectively diagnose the secondary complications and reduce the incidence of complications.The clinical diagnosis value is obvious and can be popularized in clinical practice.
, 百拇医药
Key words：Coronary atherosclerotic heart disease；Diabetes mellitus；Blood lipid；Lipoprotein-A；Apolipoprotein-B
冠状动脉粥样硬化性心脏病(coronary atherosclerotic heart disease，CHD)是临床内科常见疾病，发病率较高，且逐年增加，进而加大了CHD合并糖尿病的几率。研究显示[1]，导致糖尿病患者死亡率关键因素之一就是心血管疾病，而使CHD发生的常见因素就是血脂异常。所以，在对CHD合并糖尿病患者进行治疗时，血脂水平能为临床治疗提供有效参考信息。选取本院22例CHD合并糖尿病患者和22例CHD患者进行血脂检测，现报道如下。
1资料与方法
1.1一般资料 选取2017年1月～6月我院诊治的22例CHD合并糖尿病患者作为观察组，选取同期的22例CHD患者作为对照组，本次研究经过医院伦理委员会批准。全部患者均同意参与此次研究，排除患有精神疾病、意识语言障碍、严重肝肾器官疾病等患者。观察组男10例，女12例，年龄33～76岁，平均年龄(57.65±2.74)岁；病程1～7年，平均病程(3.41±1.02)年。对照组男13例，女9例，年龄32～75岁，平均年龄(55.32±3.01)岁；病程1～7年，平均病程(3.41±1.02)年。两组患者在性别、年龄、病程等方面差异无统计学意义(P>0.05)，具有可比性。, http://www.100md.com(刘静)